what happens when glp 1 is stopped Patients Stop Taking GLP-1 Drugs? New Cleveland Clinic Study Reveals Real World Insights Ever wonder what happens when

GLP-1 has inhibitory effects on pancreatic -cells, leading to a reduction in glucagon secretion [2-3]

However, this medication is only appropriate for patients with these specific genetic conditions and is not indicated for general weight management

As a part of creating your online account with MEDvidi, you will be prompted to share your medical history

The drug has also, reports Reuters, significantly reduced blood lipid levels and cardiovascular risk at early stages

marketed as Mounjaro for T2DM and Zepbound for obesity), is a 39-amino acid peptide acylated with a C20:0 fatty diacid moiety to lysine residue at position 20 with a molecular weight of 4.8 kDa [ Figure 2 , Table 1 ]

But it can also be prescribed off-label for weight reduction because substantial evidence supports its effectiveness